During the past decade, Hospital Nacional Cayetano Heredia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Nacional Cayetano Heredia" are "COVID" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Hospital Nacional Cayetano Heredia" in a lesser frequency.

Most popular intervention types in "Hospital Nacional Cayetano Heredia" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Acthar Gel" (1 trials), "Canakinumab" (1 trials), "Metformin" (1 trials) and "Placebo Gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nacional Cayetano Heredia" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Nacional Cayetano Heredia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Nacional Cayetano Heredia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nacional Cayetano Heredia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".